Personalized Innovative Medicine Competence Center (PERIMED)

The PERSONALISED INNOVATIVE MEDICINE Project (PERIMED) has been designed in joint collaboration among MU- Plovdiv, Plovdiv University and IMC-BAS.The project is aimed at constructing a new innovative scientific research infrastructure, focused on the integration of scientific research and development of new and newly occurring technologies.Scientific research and innovation activities have been planned for execution in the field of personalised medicine, with the accent placed on oncology, oncohaematology and intensive care medicine, innovative drug carriers for target therapy, bioengineering technologies and biosensors.Scientific research activities are of applied nature and they will contribute to the improvement of competitiveness of interdisciplinary studies to the benefit of economy and society.The project is part of the long-term strategy of the partners for development of inter-institutional collaboration with the purpose of providing support to science in Bulgaria and its turning into a factor for the development economy which is based on knowledge and innovation activities.The project envisages setting up and construction of a Competence Centre by carrying out construction and repair works and procurement of modern aparatus and special purpose equipment. 12 large-scale scientific research will be implemented under the project activities, which will include leading national and international researchers; researchers with high qualification and experience in scientific research in the country and in EU; young scientist.The project is directly related to the implementation of scientific research and development activities in technologies related to healthcare. In this context, the activities that are scheduled for execution will contribute to the construction and establishment of an infrastructural scientific complex of national importance which will be integrated successfully in the pan-European infrastructural networks in the field of personalised medicine.

Comments
Leave a comment

Overview

Status In execution (starting date)
Start date 30 Mar, 2018
End date 30 Nov, 2023
Contract date 30 Mar, 2018
View in UMIS

Financial information

Total cost 23,472,018.71
Grant 23,472,018.71
Self finance 0.00
Total paid 18,777,302.05
EU participation percent 85.0%

Location